Huličiak, M.; Vokřál, I.; Holas, O.; Martinec, O.; Štaud, F.; Červený, L.
Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices. Pharmaceuticals 2022, 15, 242.
https://doi.org/10.3390/ph15020242
AMA Style
Huličiak M, Vokřál I, Holas O, Martinec O, Štaud F, Červený L.
Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices. Pharmaceuticals. 2022; 15(2):242.
https://doi.org/10.3390/ph15020242
Chicago/Turabian Style
Huličiak, Martin, Ivan Vokřál, Ondřej Holas, Ondřej Martinec, František Štaud, and Lukáš Červený.
2022. "Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices" Pharmaceuticals 15, no. 2: 242.
https://doi.org/10.3390/ph15020242
APA Style
Huličiak, M., Vokřál, I., Holas, O., Martinec, O., Štaud, F., & Červený, L.
(2022). Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices. Pharmaceuticals, 15(2), 242.
https://doi.org/10.3390/ph15020242